Eric Libre, Eric Libre, MD, FACP, FCCP

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    GlaxoSmithKline
    Topic:
    COPD, Asthma and RSV
    Date added:
    11/28/2023
    Date updated:
    11/28/2023
    Relationship end date:
    11/28/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    AstraZeneca
    Topic:
    Asthma
    Date added:
    11/28/2023
    Date updated:
    11/28/2023
    Relationship end date:
    11/28/2023
Return to 2023 Inova Fairfax Medicine Grand Rounds (Enduring Material) 12.05.2023